Tag Archives: uthr

4 IBD 50 Stocks Poised To Bounce Back With Market

As the market bounces back after five straight sessions of losses, here’s a look at four IBD 50 stocks that could bounce back after finding support at their moving averages: United Therapeutics (UTHR), Ellie Mae (ELLI), Epam Systems (EPAM) and Illumina (ILMN). United Therapeutics staged a huge upside reversal in the stock market today, falling nearly 8% before moving to higher ground as it found support at its 200-day line. The biotech is working

United Therapeutics Plunges On Q2 Sales Miss

Big-cap biotech United Therapeutics (UTHR) disappointed investors for the second quarter in a row Tuesday, as it missed Q2 estimates and its new drug launch continued to underwhelm. The stock hit a five-month low in early trading on the stock market today . Revenue in the quarter grew 7.6% over the year-earlier quarter to $347.2 million, about $13 million below analysts’ consensus, according to Thomson Reuters. Earnings rose 14% to $2.55 a share,

United Therapeutics’ Q1 Sales Miss Hammers Stock

Big-cap biotech and IBD 50 stock United Therapeutics (UTHR) missed analysts’ Q1 estimates Tuesday as its drug sales came up short, sending the stock tumbling in early trading. United reported revenue of $327.5 million, up 13% from the year-earlier quarter but some $37 million short of consensus. Non-GAAP earnings per share rose 36% to $2.55, above analysts’ consensus of $2.14, but analysts estimate somewhat differently depending on how they